Effects of guanabenz on the adrenergic mechanism in rabbit arterial strips.

Effects of guanabenz, a hypotensive agent, on the adrenergic mechanism were studied in isolated rabbit thoracic aorta and pulmonary artery and findings were compared with data obtained with clonidine and guanethidine. Guanabenz in concentrations higher than 10(-6) M produced weak contractions which were attenuated by phentolamine or yohimbine. Such concentrations of guanabenz competitively inhibited the contractile response to noradrenaline, but did not attenuate the response to tyramine. In concentrations ranging from 10(-8) to 10(-7) M, guanabenz attenuated the contraction and the increase of 3H-efflux in response to transmural electrical stimulation of the pulmonary artery preincubated with 3H-noradrenaline. Phentolamine or yohimbine effectively blocked these inhibitory effects of guanabenz. Such effects of guanabenz were similar to those of clonidine and dissimilar to those of guanethidine. These results indicate that guanabenz acts on presynaptic and postsynaptic alpha receptors of the peripheral blood vessels, as in the case of clonidine and that the potency was almost the same as clonidine.

[1]  W. Kobinger Central α-adrenergic systems as targets for hypotensive drugs , 1978 .

[2]  S. Shibata,et al.  Vasoconstrictor and dilator actions of nicotine and electrical transmural stimulation on isolated dog cerebral arteries. , 1978, Blood vessels.

[3]  J. Walker,et al.  SELECTIVITY OF BLOCKING AGENTS FOR PRE‐ AND POSTSYNAPTIC α‐ADRENOCEPTORS , 1977 .

[4]  Adesh K. Jain,et al.  Guanabenz in essential hypertension , 1977, Clinical pharmacology and therapeutics.

[5]  S. Langer,et al.  PRESYNAPTIC RECEPTORS AND THEIR ROLE IN THE REGULATION OF TRANSMITTER RELEASE. , 1977 .

[6]  T. Baum,et al.  Studies on the centrally mediated hypotensive activity of guanabenz. , 1976, European journal of pharmacology.

[7]  D. Nash Clinical trial with guanabenz, a new antihypertensive agent. , 1973, Journal of clinical pharmacology.

[8]  K. Fuxe,et al.  Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline receptor stimulation. , 1973, European journal of pharmacology.

[9]  A. Boura,et al.  Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat , 1973, British journal of pharmacology.

[10]  K. Starke Interactions of guanethidine and indirect-acting sympathomimetic amines. , 1972, Archives internationales de pharmacodynamie et de therapie.

[11]  K. Starke,et al.  Adrenergic neuron blockade by clonidine: comparison with guanethidine and local anesthetics. , 1972, Archives internationales de pharmacodynamie et de therapie.

[12]  J. Bevan,et al.  The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. , 1970, The Journal of pharmacology and experimental therapeutics.

[13]  R. V. Van Pelt,et al.  General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678). , 1970, The Journal of pharmacology and experimental therapeutics.

[14]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.